IL131369A - Production of cross-linked amylose is useful for the controlled release of active compounds - Google Patents

Production of cross-linked amylose is useful for the controlled release of active compounds

Info

Publication number
IL131369A
IL131369A IL13136998A IL13136998A IL131369A IL 131369 A IL131369 A IL 131369A IL 13136998 A IL13136998 A IL 13136998A IL 13136998 A IL13136998 A IL 13136998A IL 131369 A IL131369 A IL 131369A
Authority
IL
Israel
Prior art keywords
cross
linked
high amylose
amylose starch
starch
Prior art date
Application number
IL13136998A
Other languages
English (en)
Hebrew (he)
Other versions
IL131369A0 (en
Inventor
Yves Dumoulin
Francois Carriere
Andre Ingenito
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Publication of IL131369A0 publication Critical patent/IL131369A0/xx
Publication of IL131369A publication Critical patent/IL131369A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B33/00—Preparation of derivatives of amylose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
IL13136998A 1997-02-14 1998-02-10 Production of cross-linked amylose is useful for the controlled release of active compounds IL131369A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/800,518 US5807575A (en) 1997-02-14 1997-02-14 Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
PCT/CA1998/000106 WO1998035992A1 (en) 1997-02-14 1998-02-10 Manufacture of cross-linked amylose useful as an excipient for control release of active compounds

Publications (2)

Publication Number Publication Date
IL131369A0 IL131369A0 (en) 2001-01-28
IL131369A true IL131369A (en) 2002-12-01

Family

ID=25178603

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13136998A IL131369A (en) 1997-02-14 1998-02-10 Production of cross-linked amylose is useful for the controlled release of active compounds

Country Status (12)

Country Link
US (1) US5807575A (de)
EP (1) EP0960131B1 (de)
AT (1) ATE212040T1 (de)
AU (1) AU726272B2 (de)
CA (1) CA2280534C (de)
DE (1) DE69803159T2 (de)
DK (1) DK0960131T3 (de)
ES (1) ES2171008T3 (de)
IL (1) IL131369A (de)
NZ (1) NZ337171A (de)
PT (1) PT960131E (de)
WO (1) WO1998035992A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
US6624200B2 (en) 1998-08-25 2003-09-23 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
EP1347748A2 (de) 2000-12-05 2003-10-01 MacGregor, Alexander Hydrostatisches abgabesystem für die kontrollierte abgabe eines mittels
CA2423712A1 (en) 2003-03-26 2004-09-26 Nicolas Nourry Crosslinked amylopectin by reactive extrusion and its use as an absorbent or superabsorbent material
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
EP1565167B1 (de) * 2002-11-07 2016-06-22 Advanced Bionutrition Corporation Nutrazeutika und verfahren zur fütterung von meerestieren
US6846497B2 (en) * 2003-01-30 2005-01-25 National Starch And Chemical Investment Holding Corporation Rapidly expanding starches with altered crystalline structure
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US8309077B2 (en) 2004-11-02 2012-11-13 Chr. Hansen A/S Stabilized bacteriophage formulations
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
EA014739B1 (ru) * 2005-09-09 2011-02-28 Лабофарм Инк. Композиция тразодона для введения один раз в день
RU2008113439A (ru) 2005-09-09 2009-10-20 Лабофарм Инк. (CA) Композиции с замедленным высвобождением лекарственного средства
US20090074829A1 (en) * 2006-03-14 2009-03-19 Masao Tanihara Novel Heparin Alternative Material and Method for Producing the Same
JP5453280B2 (ja) * 2007-10-16 2014-03-26 ラボファーム インコーポレイテッド アセトアミノフェンおよびトラマドールを持続的に放出するための二層組成物
US8563066B2 (en) * 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
AR069960A1 (es) 2007-12-28 2010-03-03 Acraf Formulacion farmaceutica de liberacion controlada y procedimiento para su preparacion
AP2975A (en) * 2008-07-16 2014-09-30 Richter Gedeon Nyrt Pharmaceutical formulations containing dopamine receptor ligands
WO2010028489A1 (en) * 2008-09-15 2010-03-18 Labopharm Inc. Starch-based microparticles for the release of agents disposed therein
SG171444A1 (en) 2009-01-23 2011-07-28 Acraf Controlled release pharmaceutical or food formulation and process for its preparation
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
GB2567493B (en) 2017-10-13 2019-12-18 Altus Formulation Inc Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4667590A (en) * 1984-12-10 1987-05-26 Mars, Inc. Closed food processing system and liquid adjustment apparatus for use therein
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
HU221591B (hu) * 1992-07-24 2002-11-28 Labopharm Inc. Keresztkötéses polihidroxil-származék enzimatikusan szabályozott hatóanyag-kibocsátáshoz

Also Published As

Publication number Publication date
ATE212040T1 (de) 2002-02-15
AU726272B2 (en) 2000-11-02
ES2171008T3 (es) 2002-08-16
EP0960131B1 (de) 2002-01-16
AU5978598A (en) 1998-09-08
CA2280534C (en) 2003-08-19
CA2280534A1 (en) 1998-08-20
WO1998035992A1 (en) 1998-08-20
DK0960131T3 (da) 2002-05-06
PT960131E (pt) 2002-06-28
DE69803159T2 (de) 2002-08-29
IL131369A0 (en) 2001-01-28
US5807575A (en) 1998-09-15
EP0960131A1 (de) 1999-12-01
NZ337171A (en) 2000-09-29
DE69803159D1 (de) 2002-02-21

Similar Documents

Publication Publication Date Title
EP0960131B1 (de) Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen
EP1305009B1 (de) Quervernetzte stark amylose haltige stärke zur verwendung in pharmazeutischen formulierungen mit kontrollierter freisetzung und verfahren zu ihrer herstellung
US9101155B2 (en) Functional starch powder
EP2694035B1 (de) Verfahren zur herstellung von cellulosederivaten mit hoher schüttdichte und guter fliessfähigkeit
EP1152026A1 (de) Polysaccharide zur Direktverpressung
AU2001271481A1 (en) Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US6616948B2 (en) Starch
EP1758939B1 (de) Eine neue generation von stärkehaltigen produkten
EP1719503B1 (de) Verwendung von Stärke mit abgespaltenen Seitenketten in der Extrudierung / Spheronisierung von pharmazeutischen Pellets
WO1999009066A1 (en) Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents
WO2003097017A1 (en) Use of completely linear short chain alpha-glucans as a pharmaceutical excipient
Ojha et al. A pharmaceutical perspective on smart polymers in drug delivery: systematic review
US20070142325A1 (en) Starch
Metta et al. A Review On: Disintegrants and Super Disintegrants with Prominence Role Of Starch As Disintegrant and its Methods of Modification
JP2007001999A (ja) 造粒組成物の製造方法
EP1325035B1 (de) Pharmazeutisch verwendbare Stärke und deren Herstellungsverfahren
JP4947613B2 (ja) 造粒組成物の製造方法
Fanta et al. Recent Processing Methods for Preparing Starch‐based Bioproducts
BeMiller Modification of Starch
CN101024084B (zh) 脱支淀粉在挤压-滚圆药丸中的用途
CN110981984A (zh) 一种高粘度羧甲基淀粉钠的制备方法
Szabo-Revesz et al. Potato starch in pharmaceutical technology-A review
TWI413532B (zh) 延長釋放的賦形劑與其應用
Shah et al. Starch-Based Delivery System

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
MM9K Patent not in force due to non-payment of renewal fees